Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiatin...
Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy
About this item
Full title
Author / Creator
Publisher
England: British Thoracic Society
Journal title
Language
English
Formats
Publication information
Publisher
England: British Thoracic Society
Subjects
More information
Scope and Contents
Contents
IntroductionFor patients with asthma who remain symptomatic on medium-dose inhaled corticosteroid/long-acting β2-agonist, add-on long-acting muscarinic antagonist is a treatment option, which can be administered as multiple-inhaler triple therapy (MITT). A high proportion of patients (61.5%–88.2%) discontinue MITT use within 1 year postinitiation;...
Alternative Titles
Full title
Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_461b821e8bf1446eb8c800654be52f96
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_461b821e8bf1446eb8c800654be52f96
Other Identifiers
ISSN
2052-4439
E-ISSN
2052-4439
DOI
10.1136/bmjresp-2023-001702
